Application of graft-derived cell-free DNA in ornithine transcarbamylase deficiency patient after living donor liver transplantation: Two case reports

RATIONALE: Graft-derived-cell-free DNA (Gcf-DNA) in plasma was a promising biomarker to monitor graft-rejection after liver transplantation. However, little is known about the application of Gcf-DNA in living-donor-liver-transplantation (LDLT). PATIENTS CONCERN: In this study, 2 patients diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Hoi-Ioi, Sun, Li-Ying, Zhu, Zhi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320025/
https://www.ncbi.nlm.nih.gov/pubmed/30572553
http://dx.doi.org/10.1097/MD.0000000000013843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320025/
https://www.ncbi.nlm.nih.gov/pubmed/30572553
http://dx.doi.org/10.1097/MD.0000000000013843

Ejemplares similares